Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mylan
Mylan
How Mylan ended as a junior partner in its Pfizer deal
Biopharma Dive
Tue, 07/30/19 - 04:20 pm
Mylan
Pfizer
Perrigo
Teva Pharmaceutical
M&A
With Mylan deal, Pfizer seeks faster growth via innovation focus
BioCentury
Mon, 07/29/19 - 11:23 pm
Pfizer
Mylan
M&A
Upjohn
innovation
What The Pfizer-Mylan Deal Means For Pharma
Forbes
Mon, 07/29/19 - 11:17 pm
Pfizer
Mylan
M&A
Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes
Marketwatch
Mon, 07/29/19 - 09:48 am
Mylan
Pfizer
M&A
Pharma CEOs
Heather Bresch
Pfizer and Mylan: Is Mega-Merger on the Horizon?
Market Realist
Mon, 07/29/19 - 09:23 am
Pfizer
off-patent
Mylan
Upjohn
M&A
Pfizer in talks to merge off-patent drugs business with Mylan -source
Yahoo/Reuters
Sat, 07/27/19 - 02:13 pm
Pfizer
Mylan
M&A
Opioid and price fixing legal liabilities mount for generic companies
Biopharma Dive
Mon, 07/22/19 - 08:08 pm
generics
opioids
price fixing
Purdue Pharma
Mylan
Endo
Amneal
Teva Pharmaceutical
Novartis amps up Symjepi launch to fill Pfizer's EpiPen supply gap
Fierce Pharma
Wed, 07/10/19 - 11:34 am
Novartis
Mylan
Pfizer
EpiPens
Sandoz
Symjepi
drug launches
Adamis Pharmaceuticals
Supply constraints push EpiPen rival maker Amneal to restructure, shares fall
Endpoints
Wed, 07/10/19 - 10:28 am
Amneal
Mylan
EpiPens
generics
With FDA spanking, Biocon and Mylan face new hurdle for Lantus challenger
Fierce Pharma
Mon, 07/8/19 - 10:18 pm
FDA
Biocon
Mylan
Sanofi
Lantus
insulin
drug manufacturing
Mylan investors favor expanding exec pay clawbacks. Will the company listen?
Fierce Pharma
Tue, 07/2/19 - 10:28 am
Mylan
executive pay
House progressives challenge drugmakers to come back to Capitol Hill
Stat
Wed, 06/12/19 - 06:52 pm
Democrats
drug pricing
Pfizer
Merck
Eli Lilly
Gilead Sciences
Mylan
Mallinckrodt
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone
CP Wire
Tue, 05/28/19 - 10:26 am
life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone
Tue, 05/28/19 - 10:24 am
life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
Hurting for revenue, Mylan shells out $130M for basket of Aspen drugs
Fierce Pharma
Mon, 05/20/19 - 12:24 pm
Mylan
Aspen Pharmacare
M&A
Australia
New Zealand
Medicaid misclassification bill inspired by EpiPen snafu passes Congress
Fierce Pharma
Wed, 04/3/19 - 12:24 pm
Mylan
generics
EpiPen
Medicaid
congress
misclassification
After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge
EP Vantage
Mon, 03/25/19 - 11:57 am
Biogen
Alzheimer's disease
Tecfidera
generics
Mylan
Mylan and Hospira both recall injected drugs after particulate discovered in vials
Fierce Pharma
Wed, 03/20/19 - 09:58 am
Mylan
Hospira
recalls
diabetes
chemotherapy
Mylan's Advair generic pressures GSK with strong launch
BioPharma Dive
Fri, 03/8/19 - 04:09 pm
GSK
Mylan
generics
Advair
Wixela Inhub
What's Behind Mylan's Disappointing Q4 Earnings?
Motley Fool
Wed, 02/27/19 - 10:48 am
Mylan
earnings
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »